home / stock / rytm / rytm quote
Last: | $38.28 |
---|---|
Change Percent: | -0.63% |
Open: | $38.39 |
Close: | $38.28 |
High: | $38.89 |
Low: | $37.36 |
Volume: | 305,047 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$38.28 | $38.39 | $38.28 | $38.89 | $37.36 | 305,047 | 04-26-2024 |
$38.15 | $38.77 | $38.15 | $38.77 | $37.36 | 424,460 | 04-25-2024 |
$39.71 | $40.57 | $39.71 | $40.99 | $39.56 | 398,306 | 04-24-2024 |
$40 | $39.39 | $40 | $41.85 | $39.19 | 413,648 | 04-23-2024 |
$39.01 | $38.31 | $39.01 | $39.42 | $37.76 | 390,372 | 04-22-2024 |
$38.01 | $37.79 | $38.01 | $39.1 | $36.92 | 615,979 | 04-19-2024 |
$38.11 | $37.83 | $38.11 | $38.9 | $37.615 | 439,034 | 04-18-2024 |
$38.45 | $39.1 | $38.45 | $39.1 | $38.25 | 599,459 | 04-17-2024 |
$38.52 | $39.59 | $38.52 | $40.13 | $38.51 | 422,152 | 04-16-2024 |
$40.09 | $40.46 | $40.09 | $41.04 | $39.955 | 621,676 | 04-15-2024 |
$40.33 | $42.01 | $40.33 | $42.01 | $39.8 | 848,662 | 04-12-2024 |
$42.58 | $41.23 | $42.58 | $42.63 | $41.1 | 421,349 | 04-11-2024 |
$41.1 | $41.93 | $41.1 | $42.67 | $40.965 | 543,943 | 04-10-2024 |
$43.61 | $41.99 | $43.61 | $43.68 | $40.79 | 380,523 | 04-09-2024 |
$41.8 | $40.81 | $41.8 | $41.935 | $40.47 | 352,340 | 04-08-2024 |
$40.54 | $39.6 | $40.54 | $41.36 | $39.25 | 465,803 | 04-05-2024 |
$40.1 | $41.51 | $40.1 | $42.195 | $39.86 | 486,299 | 04-04-2024 |
$40.89 | $39.7 | $40.89 | $40.96 | $39.43 | 447,368 | 04-03-2024 |
$40.05 | $41.76 | $40.05 | $42.0699 | $39.85 | 639,052 | 04-02-2024 |
$42.68 | $42.3 | $42.68 | $42.77 | $41.57 | 566,623 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Rhythm Pharmaceuticals Inc. Company Name:
RYTM Stock Symbol:
NASDAQ Market:
Rhythm Pharmaceuticals Inc. Website:
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that it will host a live conference call ...
2024-04-14 11:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BOSTON, April 01, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that it has signed an investment agreemen...